Skip to main content
Fig. 5 | Molecular Cancer

Fig. 5

From: Integrative analysis of CRISPR screening data uncovers new opportunities for optimizing cancer immunotherapy

Fig. 5

Construction of CTIS for predicting immunotherapeutic response. A Workflow of the construction and evaluation of CTIS. B Survival significance of CTIS in discovery dataset. C Survival of CTIS in two validation datasets. D Similarity comparison between the CTIS signature and other 14 published signatures. E Comparison of mean AUC values across all the pretreatment datasets between CTIS and other published signatures

Back to article page

Molecular Cancer

ISSN: 1476-4598